ReviewPLoS pathogens2025
Vimig: The virus-induced migrasome as a novel mechanism for viral transmission and communication.
Review in PLoS pathogens, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Vimig, defined as "virus-induced migrasome," represents a novel class of extracellular vesicles that originate from virus-infected cells. The mechanisms underlying vimig formation involve actin remodeling and upregulation of phosphatidylinositol (4,5)-bisphosphate (PI(4,5)P2). Vimig not only encapsulates viral particles but also aids in the transport of damaged organelles, including mitochondria, thereby contributing to cellular homeostasis and potentially enhancing viral spread and infection. Characterized by their unique contents, which includes viral particles, lipids, proteins, and cellular debris, vimig serves as a transmission route for viruses, possibly allowing them to evade host immune responses. This pearl summarizes the biogenesis, functional significance, and implications of vimig in viral pathogenesis, emphasizing its potential as a target for therapeutic interventions aimed at mitigating viral infections. Understanding the role of vimig may pave the way for novel strategies in clinical drug development and deepen our insights into virus-host interactions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.